Bradykinin and nerve growth factor play pivotal roles in muscular mechanical hyperalgesia after exercise (Delayed-onset muscle soreness)

Journal of Neuroscience

Volumn 30, Issue 10, 2010, Pages 3752-3761

  Murase, Shiori ^a   Terazawa, Etsuji ^a,b   Queme, Fernando ^a   Ota, Hiroki ^a   Matsuda, Teru ^a   Hirate, Kenji ^c   Kozaki, Yasuko ^a,d   Katanosaka, Kimiaki ^a   Taguchi, Toru ^a   Urai, Hisako ^a,e   Mizumura, Kazue ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Nippon Chemiphar Co Ltd   (Japan)

^d KINJO GAKUIN UNIVERSITY   (Japan)

^e OSAKA UNIVERSITY OF HEALTH AND SPORT SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; BRADYKININ ANTAGONIST; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; ICATIBANT; MESSENGER RNA; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR BETA SUBUNIT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DELAYED ONSET MUSCLE SORENESS; EXERCISE; HYPERALGESIA; MALE; MECHANICAL STIMULATION; MECHANICAL STRESS; MUSCLE CONTRACTION; MYALGIA; NOCICEPTIVE RECEPTOR; NONHUMAN; PRIORITY JOURNAL; RAT; STRETCHING; UPREGULATION;

ANIMALS; BRADYKININ; ELECTRIC STIMULATION; HYPERALGESIA; MALE; MECHANORECEPTORS; MUSCLE CONTRACTION; MUSCLE, SKELETAL; NERVE FIBERS, UNMYELINATED; PAIN MEASUREMENT; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 77949386690     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3803-09.2010     Document Type: Article

References (66)

1. Amano T, Yamakuni T, Okabe N, Sakimura K, Takahashi Y (1991) Production of nerve growth-factor in rat skeletal-muscle. Neurosci Lett 132:5-7.
2. Armstrong RB (1984) Mechanisms of exercise-induced delayed onset muscular soreness. Med Sci Sports Exerc 16:529-538.
3. Armstrong RB, Ogilvie RW, Schwane JA (1983) Eccentric exercise-induced injury to rat skeletal-muscle. J Appl Physiol 54:80-93.
4. Baker MD (2005) Protein kinase C mediates up-regulation of tetrodotoxin-resistant, persistent Na+ current in rat and mouse sensory neurones. J Physiol 567:851-867.
5. Bao G, Qadri F, Stauss B, Stauss H, Gohlke P, Unger T (1991) HOE-140, a new highly potent and long-acting bradykinin antagonist in conscious rats. Eur J Pharmacol 200:179-182.
6. Barbe MF, Barr AE, Gorzelany I, Amin M, Gaughan JP, Safadi FF (2003) Chronic repetitive reaching and grasping results in decreased motor performance and widespread tissue responses in a rat model of MSD. J Orthop Res 21:167-176.
7. Blais C Jr, Adam A, Massicotte D, Péronnet F (1999) Increase in blood bradykinin concentration after eccentric weight-training exercise in men. J Appl Physiol 87:1197-1201.
8. Boix F, Rosenborg L, Hilgenfeldt U, Knardahl S (2002) Contraction-related factors affect the concentration of a kallidin-like peptide in rat muscle tissue. J Physiol 544:127-136.
9. Carp SJ, Barbe MF, Winter KA, Amin M, Barr AE (2007) Inflammatory biomarkers increase with severity of upper-extremity overuse disorders. Clin Sci 112:305-314.
10. Chen BC, Yu CC, Lei HC, Chang MS, Hsu MJ, Huang CL, Chen MC, Sheu JR, Chen TF, Chen TL, Inoue H, Lin CH (2004) Bradykinin B2 receptor mediates NF-kappa B activation and cyclooxygenase-2 expression via the Ras/Raf-1/ERK pathway in human airway epithelial cells. J Immunol 173:5219-5228.
11. Cheung K, Hume P, Maxwell L (2003) Delayed onset muscle soreness-treatment strategies and performance factors. Sports Med 33:145-164.
12. Clarkson PM, Byrnes WC, Gillisson E, Harper E (1987) Adaptation to exercise-induced muscle damage. Clin Sci 73:383-386.
13. Crameri RM, Aagaard P, Qvortrup K, Langberg H, Olesen J, Kjaer M (2007) Myofibre damage in human skeletal muscle: effects of electrical stimulation versus voluntary contraction. J Physiol 583:365-380.
14. Dina OA, Green PG, Levine JD (2008) Role of interleukin-6 in chronic muscle hyperalgesic priming. Neuroscience 152:521-525.
15. Ferreira SH, Lorenzetti BB, Poole S (1993) Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br J Pharmacol 110:1227-1231.
16. Figueroa CD, Dietze G, MullerEsterl W (1996) Immunolocalization of bradykinin B-2 receptors on skeletal muscle cells. Diabetes [Suppl] 45:S24-S28.
17. Fjell J, Cummins TR, Davis BM, Albers KM, Fried K, Waxman SG, Black JA (1999) Sodium channel expression in NGF-overexpressing transgenic mice. J Neurosci Res 57:39-47.
18. Fox A, Wotherspoon G, McNair K, Hudson L, Patel S, Gentry C, Winter J (2003) Regulation and function of spinal and peripheral neuronal B-1 bradykinin receptors in inflammatory mechanical hyperalgesia. Pain 104:683-691.
19. Fujii Y, Ozaki N, Taguchi T, Mizumura K, Furukawa K, Sugiura Y (2008) TRP channels and ASICs mediate mechanical hyperalgesia in models of inflammatory muscle pain and delayed onset muscle soreness. Pain 140:292-304.
20. Gibson W, Arendt-Nielsen L, Graven-Nielsen T (2006) Delayed onset muscle soreness at tendon-bone junction and muscle tissue is associated with facilitated referred pain. Exp Brain Res 174:351-360.
21. Graven-Nielsen T, Arendt-Nielsen L (2003) Induction and assessment of muscle pain, referred pain, and muscular hyperalgesia. Curr Pain Headache Rep 7:443-451.
22. Hilgenfeldt U, Stannek C, Lukasova M, Schnölzer M, Lewicka S (2005) Rat tissue kallikrein releases a kallidin-like peptide from rat low-molecular-weight kininogen. Br J Pharmacol 146:958-963.
23. Hock FJ, Wirth K, Albus U, Linz W, Gerhards HJ, Wiemer G, Henke S, Breipohl G, König W, Knolle J (1991) HOE-140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br J Pharmacol 102:769-773.
24. Hoheisel U, Sander B, Mense S (1997) Myositis-induced functional reorganisation of the rat dorsal horn: effects of spinal superfusion with antagonists to neurokinin and glutamate receptors. Pain 69:219-230.
25. Hoheisel U, Unger T, Mense S (2005) Excitatory and modulatory effects of inflammatory cytokines and neurotrophins on mechanosensitive group IV muscle afferents in the rat. Pain 114:168-176.
26. Inoue A, Iwasa M, Nishikura Y, Ogawa S, Nakasuka A, Nakata Y (2006) The long-term exposure of rat cultured dorsal root ganglion cells to bradykinin induced the release of prostaglandin E2 by the activation of cyclooxygenase-2. Neurosci Lett 401:242-247.
27. Itoh K, Kawakita K (2002) Effect of indomethacin on the development of eccentric exercise-induced localized sensitive region in the fascia of the rabbit. Jpn J Physiol 52:173-180.
28. Itoh K, Okada K, Kawakita K (2004) A proposed experimental model of myofascial trigger points in human muscle after slow eccentric exercise. Acupunct Med 22:2-13.
29. Langberg H, Bjørn C, Boushel R, Hellsten Y, Kjaer M (2002) Exercise-induced increase in interstitial bradykinin and adenosine concentrations in skeletal muscle and peritendinous tissue in humans. J Physiol 542:977-983.
30. Lee CH, Shieh DC, Tzeng CY, Chen CP, Wang SP, Chiu YC, Huang CY, Hsu CJ, Fong YC, Tang CH (2008) Bradykinin-induced IL-6 expression through bradykinin B2 receptor, phosphollipase C, protein kinase C delta and NF-kappa B pathway in human synovial fibroblasts. Mol Immunol 45:3693-3702.
31. Leslie TA, Emson PC, Dowd PM, Woolf CJ (1995) Nerve growth-factor contributes to the up-regulation of growth-associated protein-43 and preprotachykinin-A messenger RNAs in primary sensory neurons following peripheral inflammation. Neuroscience 67:753-761.
32. Lewin GR, Mendell LM (1993) Nerve growth factor and nociception. Trends Neurosci 16:353-359.
33. Lewin GR, Ritter AM, Mendell LM (1993) Nerve growth factor induced hyperalgesia in the neonatal and adult-rat. J Neurosci 13:2136-2148.
34. J, King NC, Sinoway LI (2003) ATP concentrations and muscle tension increase linearly with muscle contraction. J Appl Physiol 95:577-583.
35. Malm C, Sjödin TL, Sjöberg B, Lenkei R, Renström P, Lundberg IE, Ekblom B (2004) Leukocytes, cytokines, growth factors and hormones in human skeletal muscle and blood after uphill or downhill running. J Physiol 556:983-1000.
36. Mamet J, Baron A, Lazdunski M, Voilley N (2002) Proinflammatory mediators, stimulators of sensory neuron excitability via the expression of acid-sensing ion channels. J Neurosci 22:10662-10670.
37. Mann MK, Dong XD, Svensson P, Cairns BE (2006) Influence of intramuscular nerve growth factor injection on the response properties of rat masseter muscle afferent fibers. J Orofac Pain 20:325-336.
38. Mazurek N, Weskamp G, Erne P, Otten U (1986) Nerve growth-factor induces mast-cell degranulation without changing intracellular calcium levels. FEBS Lett 198:315-320.
39. Muratani T, Doi Y, Nishimura W, Nishizawa M, Minami T, Ito S (2005) Preemptive analgesia by zaltoprofen that inhibits bradykinin action and cyclo-oxygenase in a post-operative pain model. Neurosci Res 51:427-433.
40. Nasu T, Taguchi T, Mizumura K (2010) Persistent deep mechanical hyperalgesia induced by repeated cold stress in rats. Eur J Pain 14:236-244.
41. Obata K, Katsura H, Mizushima T, Yamanaka H, Kobayashi K, Dai Y, Fukuoka T, Tokunaga A, Tominaga M, Noguchi K (2005) TRPA1 induced in sensory neurons contributes to cold hyperalgesia after inflammation and nerve injury. J Clin Invest 115:2393-2401.
42. Okamoto H, Yayama K, Shibata H, Nagaoka M, Takano M (1998) Kininogen expression by rat vascular smooth muscle cells: stimulation by lipopolysaccharide and angiotensin II. Biochim Biophys Acta 1404:329-337.
43. Pan ZK, Zuraw BL, Lung CC, Prossnitz ER, Browning DD, Ye RD (1996) Bradykinin stimulates NF-kappa B activation and interleukin 1 beta gene expression in cultured human fibroblasts. J Clin Invest 98:2042-2049.
44. Pezet S, McMahon SB (2006) Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci 29:507-538.
45. Pyne DB (1994) Exercise-induced muscle damage and inflammation: a review. Aust J Sci Med Sport 26:49-58.
46. Rabito SF, Minshall RD, Nakamura F, Wang LX (1996) Bradykinin B-2 receptors on skeletal muscle are coupled to inositol 1,4,5-trisphosphate formation. Diabetes 45:S29-S33.
47. Russell IJ, Bieber CS (2006) Myofascial pain and fibromyalgia syndrome. In: Textbook of pain, Ed 5 (Mcmahon SB, Koltzenburg M, eds), pp 669-681. Amsterdam: Elsevier/Churchill/Livingstone.
48. Shelton DL, Zeller J, Ho WH, Pons J, Rosenthal A (2005) Nerve growth factor mediates hyperalgesia and cachexia in auto-immune arthritis. Pain 116:8-16.
49. Shu X, Mendell LM (1999) Nerve growth factor acutely sensitizes the response of adult rat sensory neurons to capsaicin. Neurosci Lett 274:159-162.
50. Sluka KA, Kalra A, Moore SA (2001) Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia. Muscle Nerve 24:37-46.
51. Smith LL (1991) Acute-inflammation - the underlying mechanism in delayed onset muscle soreness. Med Sci Sports Exerc 23:542-551.
52. Summer GJ, Romero-Sandoval EA, Bogen O, Dina OA, Khasar SG, Levine JD (2008) Proinflammatory cytokines mediating burn-injury pain. Pain 135:98-107.
53. Svensson P, Cairns BE, Wang K, Arendt-Nielsen L (2003) Injection of nerve growth factor into human masseter muscle evokes longlasting mechanical allodynia and hyperalgesia. Pain 104:241-247.
54. Taguchi T, Kishikawa H, Motoshima H, Sakai K, Nishiyama T, Yoshizato K, Shirakami A, Toyonaga T, Shirontani T, Araki E, Shichiri M (2000) Involvement of bradykinin in acute exercise-induced increase of glucose uptake and GLUT-4 translocation in skeletal muscle: studies in normal and diabetic humans and rats. Metabolism 49:920-930.
55. Taguchi T, Matsuda T, Tamura R, Sato J, Mizumura K (2005a) Muscular mechanical hyperalgesia revealed by behavioural pain test and c-Fos expression in the spinal dorsal horn after eccentric contraction in rats. J Physiol 564:259-268.
56. Taguchi T, Sato J, Mizumura K (2005b) Augmented mechanical response of muscle thin-fiber sensory receptors recorded from rat muscle-nerve preparations in vitro after eccentric contraction. J Neurophysiol 94:2822-2831.
57. Takahashi K, Taguchi T, Itoh K, Okada K, Kawakita K, Mizumura K (2005) Influence of surface anesthesia on the pressure pain threshold measured with different-sized probes. Somatosens Mot Res 22:299-305.
58. Takano M, Sakanaka F, Yayama K, Okamoto H (2000) Tissue-specific expression of rat kininogen mRNAs. Biol Pharm Bull 23:1239-1242.
59. Tegeder L, Zimmermann J, Meller ST, Geisslinger G (2002) Release of algesic substances in human experimental muscle pain. Inflamm Res 51:393-402.
60. Tillu DV, Gebhart GF, Sluka KA (2008) Descending facilitatory pathways from the RVM initiate and maintain bilateral hyperalgesia after muscle insult. Pain 136:331-339.
61. Toti P, Villanova M, Vatti R, Schuerfeld K, Stumpo M, Barbagli L, Malandrini A, Costantini M (2003) Nerve growth factor expression in human dystrophic muscles. Muscle Nerve 27:370-373.
62. Turrini P, Gaetano C, Antonelli A, Capogrossi MC, Aloe L (2002) Nerve growth factor induces angiogenic activity in a mouse model of hindlimb ischemia. Neurosci Lett 323:109-112.
63. Wirth K, Breipohl G, Stechl J, Knolle J, Henke S, Schölkens B (1991) DesArg9-D-Arg[Hyp3,Thi5,D-Tic7,Oic8]bradykinin (desArg10-[Hoe140]) is a potent bradykinin B1 receptor antagonist. Eur J Pharmacol 205:217-218.
64. Woolf CJ, Safieh-Garabedian B, Ma QP, Crilly P, Winter J (1994) Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience 62:327-331.
65. Woolf CJ, Ma QP, Allchorne A, Poole S (1996) Peripheral cell types contributing to the hyperalgesic action of nerve growth factor in inflammation. J Neurosci 16:2716-2723.
66. Zhang X, Huang J, McNaughton PA (2005) NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels. EMBO J 24:4211-4223.